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represent the interest and idiosyncrasies of
the editors and, as often occurs, the delay
between data availability and publication
necessarily means that many of the studies
have been up-dated several times by the
publication of this particular volume. None
the less this book is a further volume in an
important series ofup-dates for thepractising
cancer clinician, and will find its way into his
library as before.
With the advent of specialist monographs
on many of the subjects covered here, one
might question thevalidity ofsuch a volume,
but for the eclectic and broadly based reader
the Year Book o Cancer still provides man f y
interesting items of information from a very
wide area of cancer clinical practice and re-
search, and is thoroughly recommended on
that ground alone.
H. Busi-i
Topics in Toxicology: Mutagenesis in
Sub-Mammalian Systems. Status and
Significance. ED. G. E. PAGET (1979).
M.T.P. Press. 231 pp. Y,8.95.
The book covers theproceedings of a meet-
ing held under the auspices of Inveresk Re-
search International to discuss topics of cur-
rent interest ingenetictoxicology. It contains
a mixed bag of papers of variable scientific
standard on topics ranging from the sig-
nificance of DNA damage for man to discus-
sion ofpracticallaboratory details in relation
to the Ames test. The book purports to be
about sub-mammalian systems, but some
papers deal, albeit in a rather superficial
manner, with DNA-repair tests, point muta-
tion and transformation assays in mammalian
ce,11s. The participants of the meeting were
mainly from industriallaboratories, and their
discussion of the various tests is largely con-
cerned with their usefulness in large-scale
screening, their validation and the problems
oftesting unknown compounds. As such, the
book isprobably ofinterest to those involved
in such testing, but of limited value to the
general scientific community because of the
superficial coverage ofmost ofthetopics, and
because most of the information is available
in a much more detailed form in the general
scientific literature. There have been numer-
ous such publications recently and this one
certainly adds little (ifany) new information.
M. Fox
Human Malignant Melanoma. Eds. W. H.
CLARK, L. 1. GOLDMAN and M. J. MASTRAN-
GELO (1979) ClinicalOncologyMonographs.
New York: Grune & Stratton. 509 pp.
Inthepastfewyearsseveraltextbookshave
appeared on the subject of malignant
melanoma, and it is therefore important to
examine new books of this type as they are
published to see just what part of the gaps
in our knowledge of this important condition
are being filled. This particular monograph is
mainly the work of the Philadelphia group,
and is an important and useful contribution
to ourknowledge. It has 3 sections. The first,
and by far the largest, is devoted to primary
cutaneousmalignant melanoma, and includes
discussion of the concept of tumour progres-
sion, detailed descriptions of pathology, and
discussion on some of the aspects of epi-
demiology of current importance. Section
two concerns the treatment of cutaneous
human malignant melanoma, and covers sur-
gery, perfusion, post-surgical adjuvant ther-
apy, chemotherapy, immunotherapy and
irradiation. The third section is on ocular
melanomas and covers malignant melanoma
of both the conjunctiva and the uveal tract.
I found this particularly valuable, in view of
the lack ofworkcurrently available on ocular
inalignant melanoma.
New points which are brought out in this
publicationincludetheseparation ofanentity
called a pigmented spindle-cell tumour from
the Spitz tumour/juvenile melanoma. In the
section onpathology the concept ofthe prog-
nostic value of both depth of tumour (ad-
vanced by Clark) and the thickness of the
tumour (advocated by Breslow) are dis-
cussed, but as more laboratories without par-
ticular knowledge of melanoma are now
measuring these parameters and including
them in routine reports to clinicians, some
critical discussion would be useful For
example, it is clear that tumour thickness
will varyaccording to the fixative, thelength
of time in fixative and the subsequent pro-
cessing. It would be valuable if one of the
laboratories which handle large quantities of
melanoma could study the effect of these
variables on tumour thickness. The discussion
on malignant melanoma of the oral cavity
underlines that this is an underworked area
badly needing further studies, by dermatolo-
gists or specialists in oral medicine.
In section two thesurgical results discussed